These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31181285)

  • 1. Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study.
    Greenberg D; Dagan R; Shany E; Ben-Shimol S; Givon-Lavi N
    Clin Microbiol Infect; 2020 Feb; 26(2):256.e1-256.e5. PubMed ID: 31181285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data.
    Kong AM; Winer IH; Zimmerman NM; Diakun D; Bloomfield A; Gonzales T; Fergie J; Goldstein M; Krilov LR
    Am J Perinatol; 2023 Oct; 40(14):1529-1536. PubMed ID: 34704241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy Late-preterm infants born 33-36+6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization.
    Helfrich AM; Nylund CM; Eberly MD; Eide MB; Stagliano DR
    Early Hum Dev; 2015 Sep; 91(9):541-6. PubMed ID: 26186560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy.
    Ciarlitto C; Vittucci AC; Antilici L; Concato C; Di Camillo C; Zangari P; Villani A
    Ital J Pediatr; 2019 Aug; 45(1):115. PubMed ID: 31462274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Syncytial Virus Associated Hospitalizations in Infants of 33 to 42 Weeks' Gestation: Does Gestational Age Matter?
    Resch B; Wörner C; Özdemir S; Hubner M; Puchas C; Urlesberger B
    Klin Padiatr; 2019 Jul; 231(4):206-211. PubMed ID: 30887492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk for respiratory syncytial virus-associated, community-acquired alveolar pneumonia in infants born at 31-36 weeks of gestation.
    Greenberg D; Dagan R; Shany E; Bar-Ziv J; Givon-Lavi N
    Pediatr Infect Dis J; 2014 Apr; 33(4):381-6. PubMed ID: 24145171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era.
    Resch B; Egger B; Kurath-Koller S; Urlesberger B
    Int J Infect Dis; 2017 Apr; 57():50-53. PubMed ID: 28163166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization of Late Premature Versus Term Infants With Bronchiolitis.
    Greenberg D; Dagan R; Shany E; Ben-Shimol S; Givon-Lavi N
    Clin Pediatr (Phila); 2020 Jul; 59(8):778-786. PubMed ID: 32400172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations.
    Bennett MV; McLaurin K; Ambrose C; Lee HC
    PLoS One; 2018; 13(10):e0205399. PubMed ID: 30379957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020.
    Packnett ER; Winer IH; Larkin H; Oladapo A; Gonzales T; Wojdyla M; Goldstein M; Smith VC
    Hum Vaccin Immunother; 2022 Nov; 18(6):2140533. PubMed ID: 36412253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
    Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
    Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
    An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study.
    Silvestri M; Marando F; Costanzo AM; di Luzio Paparatti U; Rossi GA
    Ital J Pediatr; 2016 Apr; 42():40. PubMed ID: 27112952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.
    Gouyon JB; Rozé JC; Guillermet-Fromentin C; Glorieux I; Adamon L; DI Maio M; Miloradovich T; Anghelescu D; Pinquier D; Escande B; Elleau C
    Epidemiol Infect; 2013 Apr; 141(4):816-26. PubMed ID: 22697130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012.
    Sanchez-Luna M; Elola FJ; Fernandez-Perez C; Bernal JL; Lopez-Pineda A
    Curr Med Res Opin; 2016; 32(4):693-8. PubMed ID: 26709735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
    Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
    Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.